NASDAQ NMS - GLOBAL MARKET · FLNA
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Filana Therapeutics Inc

Filana Therapeutics Inc

Pharmaceuticals
$0.8900
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
FLNA
Filana Therapeutics Inc
Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

72/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FLNA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FLNA catalysts
About Filana Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2000
Employees
20
Country
US

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8900
Last session
Day high
$0.8900
Last session
Day low
$0.8900
Last session
Previous close
$0.8900
52W high
$2.09
-57.42% from high
52W low
$0.8696
2% of range
Market cap
$44.1M
EPS
$-0.2100
Beta
1.65
Shares out
48.3M
Avg volume
348.1K
VWAP
$0.8900
Last session
Price history computed in-house
1W
-8.40%
1M
-16.04%
3M
-28.80%
SMA 50 $1.11 · below
SMA 200 Not reported · Not reported
52W position 2%

FLNA overview

Veridion Score
72
Daily close · 2026-08-17
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FLNA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FLNA Form 4 filings
Public disclosures

Congress activity in FLNA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for FLNA in the cached public ledger.

Federal contracts

FLNA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FLNA in this window.
Lobbying spend

FLNA lobbying filings, year to date.

Registered lobbying filings matched to Filana Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FLNA in this window.
Loading news for FLNA
Analyst ratings
Sovereign unlock shows live analyst consensus for FLNA.
Options
Sovereign unlock shows live options positioning for FLNA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.